Epigenetic regulator SMCHD1 functions as a tumor suppressor

Cancer Research

Volumn 73, Issue 5, 2013, Pages 1591-1599

  Leong, Huei San ^a,b   Chen, Kelan ^a,b   Hu, Yifang ^a   Lee, Stanley ^a,b   Corbin, Jason ^b   Pakusch, Miha ^b   Murphy, James M ^a,b   Majewski, Ian J ^e   Smyth, Gordon K ^a,c   Alexander, Warren S ^a,b   Hilton, Douglas J ^a,b   Blewitt, Marnie E ^a,b,d  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b Departments of Medical Biology   (Australia)

^c Department of Mathematics and Statistics ^*  (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN; PROTEIN SMCHD1; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CHIMERA; CONTROLLED STUDY; DISEASE ACTIVITY; EMBRYO; EPIGENETICS; FETUS; GENE EXPRESSION PROFILING; GENE INACTIVATION; GENE REPRESSION; LEUKEMIA; LYMPHOCYTE COUNT; LYMPHOMA; LYMPHOMAGENESIS; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE MYC; PERIPHERAL LYMPHOCYTE; PRE B LYMPHOCYTE; PRECANCER; PRIORITY JOURNAL; PROTEIN DEPLETION; SMCHD1 GENE; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMAL PROTEINS, NON-HISTONE; DOWN-REGULATION; EPIGENESIS, GENETIC; FIBROBLASTS; GENE KNOCKOUT TECHNIQUES; GENES, TUMOR SUPPRESSOR; HUMANS; LYMPHOMA, B-CELL; MALE; MICE; MICE, NUDE; MICE, TRANSGENIC;

EID: 84874870145     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-3019     Document Type: Article

References (43)

1. Blewitt ME, Vickaryous NK, Hemley SJ, Ashe A, Bruxner TJ, Preis JI, et al. An N-ethyl-N-nitrosourea screen for genes involved in variegation in the mouse. Proc Natl Acad Sci U S A 2005;102:7629-34.
2. Blewitt ME, Gendrel AV, Pang Z, Sparrow DB, Whitelaw N, Craig JM, et al.SmcHD1, containing a structural-maintenance-of-chromosomes hinge domain, has a critical role in X inactivation. Nat Genet 2008; 40:663-9.
3. Hirano T. At the heart of the chromosome: SMC proteins in action. Nat Rev Mol Cell Biol 2006;7:311-22.
4. Kanwal R, Gupta S. Epigenetic modifications in cancer. Clin Genet 2012;81:303-11.
5. Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S, et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 1985; 318:533-8.
6. Egle A, Harris AW, Bouillet P, Cory S. Bim is a suppressor of Mycinduced mouse B cell leukemia. Proc Natl Acad Sci U S A 2004;101: 6164-9.
7. Majewski IJ, Blewitt ME, de Graaf CA, McManus EJ, Bahlo M, Hilton AA, et al. Polycomb repressive complex 2 (PRC2) restricts hematopoietic stem cell activity. PLoS Biol 2008;6:e93.
8. Serrano M, Lin AW,McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997;88:593-602.
9. Dickins RA, Hemann MT, Zilfou JT, Simpson DR, Ibarra I, Hannon GJ, et al. Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat Genet 2005;37:1289-95.
10. Ripoll GV, Giron S, Krzymuski MJ, Hermo GA, Gomez DE, Alonso DF. Antitumor effects of desmopressin in combination with chemotherapeutic agents in a mouse model of breast cancer. Anticancer Res 2008;28:2607-11.
11. Vert JP, Foveau N, Lajaunie C, Vandenbrouck Y. An accurate and interpretable model for siRNA efficacy prediction. BMC Bioinformatics 2006;7:520.
12. DSIR France: CEA; 2007 [updated 2009 Jul 28; cited 2008 Jun 1]. Available from: Http://biodev.cea.fr/DSIR/DSIR.html.
13. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al. Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol 2004;5:R80.
14. Shi W, Oshlack A, Smyth GK. Optimizing the noise versus bias tradeoff for Illumina whole genome expression BeadChips. Nucleic Acids Res 2010;38:e204.
15. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004;3:Article3.
16. Ritchie ME, Diyagama D, Neilson J, van Laar R, Dobrovic A, Holloway A, et al. Empirical array quality weights in the analysis of microarray data. BMC Bioinformatics 2006;7:261.
17. Smyth GK, Michaud J, Scott HS. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 2005;21:2067-75.
18. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Roy Stat Soc Ser B 1995;57:289-300.
19. Wu D, Smyth GK. Camera: A competitive gene set test accounting for inter-gene correlation. Nucleic Acids Res 2012;40:e133.
20. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005;102:15545-50.
21. Jackson LaboratoryMammalian Orthology Tables [Internet]. The Jackson Laboratory. [cited 2012 Mar 8]. Available from: Https://http://www. informatics.jax.org/orthology.shtml.
22. WEHI bioinformatics MSigDB software Melbourne: Walter and Eliza hall institute bioinformatics division; [cited 2012 Mar 8]. Available from: Http://bioinf.wehi.edu.au/software.MSigDB.
23. WEHI bioinformatics compare curves software Melbourne: Walter and Eliza hall institute bioinformatics division; [cited 2009 Sept 1]. Available from: Http://bioinf.wehi.edu.au/software/compareCurves/.
24. Elso CM, Roberts LJ, Smyth GK, Thomson RJ, Baldwin TM, Foote SJ, et al. Leishmaniasis host response loci (lmr1-3) modify disease severity through a Th1/Th2-independent pathway. Genes Immun 2004;5: 93-100.
25. Hu Y, Smyth GK. ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods 2009;347:70-8.
26. Wu C, Orozco C, Boyer J, Leglise M, Goodale J, Batalov S, et al. BioGPS: An extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 2009;10:R130.
27. BioGPS [Internet]. Scripps Research Institute. [cited 2012 June 1]. Available from: Http://biogps.gnf.org.
28. Langdon WY, Harris AW, Cory S, Adams JM. The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice. Cell 1986;47:11-8.
29. Held W, Roland J, Raulet DH. Allelic exclusion of Ly49-family genes encoding class I MHC-specific receptors on NK cells. Nature 1995; 376:355-8.
30. Esumi S, Kakazu N, Taguchi Y, Hirayama T, Sasaki A, Hirabayashi T, et al.Monoallelic yet combinatorial expression of variable exons of the protocadherin-alpha gene cluster in single neurons. Nat Genet 2005;37:171-6.
31. Taniura H, Taniguchi N, Hara M, Yoshikawa K. Necdin, a postmitotic neuron-specific growth suppressor, interacts with viral transforming proteins and cellular transcription factor E2F1. J Biol Chem 1998; 273:720-8.
32. Taniura H, Matsumoto K, Yoshikawa K. Physical and functional interactions of neuronal growth suppressor necdin with p53. J Biol Chem 1999;274:16242-8.
33. Fu B, Luo M, Lakkur S, Lucito R, Iacobuzio-Donahue CA. Frequent genomic copy number gain and overexpression of GATA-6 in pancreatic carcinoma. Cancer Biol Ther 2008;7:1593-601.
34. Li S, Phong M, Lahn M, Brail L, Sutton S, Lin BK, et al. Retrospective analysis of protein kinase C-beta (PKC-beta) expression in lymphoid malignancies and its association with survival in diffuse large B-cell lymphomas. Biol Direct 2007;2:8.
35. Umemura A, Itoh Y, Itoh K, Yamaguchi K, Nakajima T, Higashitsuji H, et al. Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma. Hepatology 2008; 47:493-502.
36. Gu Y, Nakamura T, Alder H, Prasad R, Canaani O, Cimino G, et al. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell 1992;71:701-8.
37. Nakamura T, Alder H, Gu Y, Prasad R, Canaani O, Kamada N, et al. Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs. Proc Natl Acad Sci U S A 1993;90:4631-5.
38. Ross ME, Mahfouz R, Onciu M, Liu HC, Zhou X, Song G, et al. Gene expression profiling of pediatric acute myelogenous leukemia. Blood 2004;104:3679-87.
39. Gaussmann A, Wenger T, Eberle I, Bursen A, Bracharz S, Herr I, et al. Combined effects of the two reciprocal t(4;11) fusion proteins MLL.AF4 and AF4.MLL confer resistance to apoptosis, cell cycling capacity and growth transformation. Oncogene 2007; 26:3352-63.
40. Oncomine.org [Internet]. Compendia Bioscience C2008-2012. [cited 2012 July 31]. Available from: Http://www.oncomine.org.
41. CONAN: Copy number analysis [Internet]. Welcome Trust Sanger Institute. [cited 2012 July 31]. Available from: Http://www.sanger.ac. uk/cgi-bin/genetics/ CGP/conan/search.cgi.
42. The Cancer Genome Atlas [Internet]. National Cancer Institute and National Genome Research Institute. [cited 2012 Jul 31]. Available from: Http://cancergenome.nih.gov/.
43. Lemmers RJ, Tawil R, Petek LM, Balog J, Block GJ, Santen GW, et al. Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat Genet 2012;44:1370-4.